UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $104.00

Colgate-Palmolive (NYSE:CL) had its target price cut by UBS Group from $112.00 to $104.00 in a research report released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other analysts also recently issued reports on the stock. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $88.79 on Thursday. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The firm’s 50 day simple moving average is $92.20 and its 200-day simple moving average is $97.74. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.37% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CL. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth $1,315,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive in the 3rd quarter worth $602,000. Carrera Capital Advisors increased its holdings in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the period. Vontobel Holding Ltd. raised its position in shares of Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after buying an additional 550,750 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $4,066,000. 80.41% of the stock is owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.